A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma

被引：0
|
作者：
Shuji Hiramoto
Ken Kato
Hirokazu Shoji
Natsuko Okita
Atsuo Takashima
Yoshitaka Honma
Satoru Iwasa
Tetsuya Hamaguchi
Yasuhide Yamada
Yasuhiro Shimada
Narikazu Boku
机构：
[1] National Cancer Center Hospital,Gastrointestinal Medical Oncology Division
[2] Mitsubishi Kyoto Hospital,Department of Clinical Oncology and Palliative Medicine
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Metastatic/recurrent esophageal cancer; First-line chemotherapy; 5-Fluorouracil + cisplatin; Prognostic factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：466 / 472
页数：6
相关论文
共 50 条
  • [1] A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma
    Hiramoto, Shuji
    Kato, Ken
    Shoji, Hirokazu
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Iwasa, Satoru
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    Boku, Narikazu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 466 - 472
  • [2] A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in patients with metastatic or recurrent esophageal squamous cell carcinoma.
    Hiramoto, Shuji
    Kato, Ken
    Shoji, Hirokazu
    Okita, Natsuko T.
    Takashima, Atsuo
    Honma, Yoshitaka
    Iwasa, Satoru
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [3] A retrospective analysis of 5-fluorouracil plus cisplatin in metastatic or recurrent esophageal squamous cell carcinoma
    Hiramoto, Shuji
    Kato, Ken
    Shoji, Hirokazu
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Iwasa, Satoru
    Hmaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 114 - 114
  • [4] Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
    Lin, Ying-Tao
    Zhou, Chong-Chong
    Xu, Kai
    Zhang, Meng-Die
    Li, Xin
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [5] Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer
    Liu, Ying
    Ren, Zhonghai
    Yuan, Long
    Xu, Shuning
    Yao, Zhihua
    Qiao, Lei
    Li, Ke
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (10): : 2345 - 2350
  • [6] Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment
    Kajiura, Shinya
    Hosokawa, Ayumu
    Yoshita, Hiroki
    Ueda, Yuko
    Ueda, Akira
    Mihara, Hiroshi
    Ando, Takayuki
    Fujinami, Haruka
    Nishikawa, Jun
    Ogawa, Kohei
    Minemura, Masami
    Sugiyama, Toshiro
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 13 - 17
  • [7] Tislelizumab plus chemotherapy as first-line treatment for unresectable, locally advanced recurrent/metastatic esophageal squamous cell carcinoma
    Yoon, Harry H.
    Kato, Ken
    Hubner, Richard
    Raymond, Eric
    Tao, Aiyang
    Liu, Sumei
    Qazi, Ibrahim
    Xu, Jian-Ming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [8] First-line cisplatin plus bolus 5-Fluorouracil combination in patients with locally advanced and metastatic esophageal cancer
    Akyol, M.
    Kucukzeybek, Y.
    Varol, U.
    Yildiz, I.
    Cokmert, S.
    Bayoglu, I. V.
    Yildiz, Y.
    Demir, L.
    Can, A.
    Dirican, A.
    Alacacioglu, A.
    Tarhan, M. O.
    [J]. ANNALS OF ONCOLOGY, 2015, 26
  • [9] Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
    Lin, Chia-Chi
    Yeh, Kun-Huei
    Yang, Chih-Hsin
    Hsu, Chiun
    Tsai, Yu-Chieh
    Hsu, Wei-Ling
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    [J]. ANTI-CANCER DRUGS, 2007, 18 (06) : 703 - 708
  • [10] Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin
    Kawabata, Ryohei
    Imamura, Hiroshi
    Kishimoto, Tomono
    Kitamura, Shinji
    Hachino, Yoshimi
    Yasui, Yukako
    Fujino, Misako
    Fujii, Chika
    Furukawa, Hiroshi
    [J]. ESOPHAGUS, 2011, 8 (03) : 179 - 185
12345